Status: current, Defined. Date: 30-Sep 2014. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1332561000168111 | Gaviscon Infant (magnesium alginate 87.5 mg + sodium alginate 225 mg) powder for oral liquid, 30 sachets (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1332571000168117 | Gaviscon Infant powder for oral liquid, 30 sachets | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Gaviscon Infant powder for oral liquid, 30 sachets | Is a | trade product pack | true | Inferred relationship | Some | ||
| Gaviscon Infant powder for oral liquid, 30 sachets | Is a | sodium alginate 225 mg + magnesium alginate 87.5 mg powder for oral liquid, 30 sachets | true | Inferred relationship | Some | ||
| Gaviscon Infant powder for oral liquid, 30 sachets | has TPUU | Gaviscon Infant powder for oral liquid, 1 sachet | true | Inferred relationship | Some | 1 | |
| Gaviscon Infant powder for oral liquid, 30 sachets | has TP | Gaviscon Infant | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Gaviscon Infant (magnesium alginate 87.5 mg + sodium alginate 225 mg) powder for oral liquid, 30 sachets (containered trade product pack) | Is a | True | Gaviscon Infant powder for oral liquid, 30 sachets | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR